Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers
2012 · Nano Today · 196 citations
https://doi.org/10.1016/j.nantod.2012.06.010
B
B. Mark Evers
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
602
Papers
22.0K
Citations
84
h-index
291
i10-index
B. Mark Evers is an academic researcher from University of Kentucky. The author has contributed to research in topics: Neuropeptides and Animal Physiology & Neuroendocrine Tumor Research Advances & PI3K/AKT/mTOR signaling in cancer. The author has an h-index of 84, co-authored 512 publications.
ORCID: 0000-0002-9425-2342Papers by this author
worksDub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation
2017 · Nature Communications · 131 citations
https://doi.org/10.1038/ncomms14228
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
2018 · Nature Communications · 103 citations
https://doi.org/10.1038/s41467-018-07258-y
Small C-terminal Domain Phosphatase Enhances Snail Activity through Dephosphorylation
2008 · Journal of Biological Chemistry · 102 citations
https://doi.org/10.1074/jbc.m806916200
TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium
2015 · Cell Death and Disease · 69 citations
https://doi.org/10.1038/cddis.2014.588
S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2
2019 · Journal of Biological Chemistry · 69 citations
https://doi.org/10.1074/jbc.ra118.004365
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat